Reclast, also known by its generic name zoledronic acid, is a bisphosphonate medication used to treat osteoporosis and prevent fractures in certain patients [1]. It is also used to treat Paget's disease of bone and to manage hypercalcemia of malignancy [1].
What is Reclast used for?
Reclast is primarily prescribed for postmenopausal osteoporosis to reduce the risk of vertebral, non-vertebral, and hip fractures. It is also indicated for men with osteoporosis to reduce the risk of fractures, and for glucocorticoid-induced osteoporosis in men and women [1]. Additionally, Reclast treats Paget's disease of bone, characterized by abnormal bone remodeling, and is used to manage hypercalcemia (high calcium levels) associated with cancer [1].
How does Reclast work?
As a bisphosphonate, Reclast works by slowing down bone loss [1]. It inhibits osteoclast activity, the cells responsible for breaking down bone tissue. By reducing bone resorption, Reclast helps to increase bone mineral density and improve bone strength, thereby lowering the risk of fractures [1].
What are the common side effects of Reclast?
Common side effects associated with Reclast infusion include flu-like symptoms such as fever, fatigue, chills, and bone pain [1]. Other potential side effects include nausea, muscle pain, and pain in arms or legs [1].
Are there serious risks associated with Reclast?
Serious risks associated with Reclast include osteonecrosis of the jaw (ONJ), a condition where bone tissue in the jaw dies, and atypical femur fractures, which are breaks in the thigh bone that can occur with minimal trauma [1]. Both of these side effects are rare but require medical attention [1]. Patients may also experience kidney problems, particularly if they have pre-existing kidney disease or receive the infusion too quickly [1]. In some cases, severe bone, joint, or muscle pain has been reported [1].
Who makes Reclast?
Reclast is manufactured by Novartis [2].
When does Reclast patent expire?
Information regarding specific patent expiry dates for Reclast is typically proprietary and managed by the pharmaceutical company. DrugPatentWatch.com provides resources for tracking patent information on pharmaceuticals [3]. Generally, the exclusivity for brand-name drugs like Reclast is determined by patent protection and regulatory exclusivities, which can vary by region and are subject to challenges and extensions.
Can generic versions of Reclast be available?
Once patent protection and any associated market exclusivities expire, generic versions of Reclast can become available, provided regulatory approval is obtained [3]. The availability of generics can lead to lower medication costs.